• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清促甲状腺激素浓度与甲状腺癌发病率之间的关联

[Association between the serum TSH concentration and thyroid cancer incidence].

作者信息

Li Jian-zhou, Jin Yong-jun, Liu Xin, Zhang Ling-yun

机构信息

Department of Endocrinology, Binzhou Medical College Hospital, Binzhou 256603, Binzhou, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):921-4.

PMID:22340102
Abstract

OBJECTIVE

To investigate the association between serum TSH concentration and thyroid cancer incidence.

METHODS

Three hundred and thirty patients with thyroid tumors who underwent surgical treatment were included in this study (99 cases of malignancy and 231 cases of benign tumors). The data of their serum TSH level, gender, age, tumor type, and number of tumors detected by ultrasonic inspection were retrospectively analyzed, and their association with thyroid cancer incidence was explored.

RESULTS

The proportion of thyroid cancer in the groups of younger than twenty years and older than seventy years were 63.0% and 58.3%, respectively, significantly higher than that in the group of age between 60 and 69 years (23.3%, P < 0.05). The incidence of thyroid cancer of the 81 male patients was 43.2%, significantly higher than that in the 249 female patients (25.7%, P = 0.003). The incidence of thyroid cancer in the 112 patients with single nodule was 42.0%, significantly higher than that in the 218 patients with multiple nodules (23.9%, P < 0.001). In the groups with TSH level lower than 0.28 mIU/L and higher than 4.20 mIU/L, the incidence of thyroid cancer were 54.6% and 50.0%, respectively, significantly higher than that in the group with TSH level between 0.28 and 1.44 mIU/L (16.1%, P < 0.05). The proportion of patients with thyroid cancer was also increased with the increasing serum TSH level in the normal range (P < 0.001). High serum TSH level (OR = 1.465, P = 0.014), male (OR = 1.964, P = 0.016) and a single thyroid nodule (OR = 2.090, P = 0.006) are independent risk factors of thyroid cancer.

CONCLUSION

The high serum TSH level, male, single thyroid nodule are factors leading to a high incidence of thyroid cancer.

摘要

目的

探讨血清促甲状腺激素(TSH)浓度与甲状腺癌发病率之间的关联。

方法

本研究纳入330例接受手术治疗的甲状腺肿瘤患者(99例恶性肿瘤和231例良性肿瘤)。回顾性分析其血清TSH水平、性别、年龄、肿瘤类型以及超声检查发现的肿瘤数量等数据,并探讨它们与甲状腺癌发病率的关联。

结果

20岁以下组和70岁以上组甲状腺癌的比例分别为63.0%和58.3%,显著高于60至69岁组(23.3%,P<0.05)。81例男性患者甲状腺癌的发病率为43.2%,显著高于249例女性患者(25.7%,P = 0.003)。112例单发结节患者甲状腺癌的发病率为42.0%,显著高于218例多发结节患者(23.9%,P<0.001)。TSH水平低于0.28 mIU/L组和高于4.20 mIU/L组甲状腺癌的发病率分别为54.6%和50.0%,显著高于TSH水平在0.28至1.44 mIU/L组(16.1%,P<0.05)。在正常范围内,甲状腺癌患者的比例也随血清TSH水平升高而增加(P<0.001)。血清TSH水平高(OR = 1.465,P = 0.014)、男性(OR = 1.964,P = 0.016)和单发甲状腺结节(OR = 2.090,P = 0.006)是甲状腺癌的独立危险因素。

结论

血清TSH水平高(OR = 1.465,P = 0.014)、男性(OR = 1.964,P = 0.016)和单发甲状腺结节(OR = 2.090,P = 0.006)是导致甲状腺癌高发病率的因素。

相似文献

1
[Association between the serum TSH concentration and thyroid cancer incidence].血清促甲状腺激素浓度与甲状腺癌发病率之间的关联
Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):921-4.
2
Clinicopathological correlation of serum TSH in patients with thyroid nodule.甲状腺结节患者血清促甲状腺激素的临床病理相关性
J Indian Med Assoc. 2011 May;109(5):330, 335, 338.
3
[Association between preoperative serum thyroid-stimulating hormone level and nonfunctioning malignant nodule thyroid disease].[术前血清促甲状腺激素水平与无功能恶性结节性甲状腺疾病的关联]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Dec;28(24):1931-3.
4
Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.血清促甲状腺激素水平升高与甲状腺微小乳头状癌风险之间缺乏关联。
Head Neck. 2014 Jan;36(1):43-6. doi: 10.1002/hed.23252. Epub 2013 Jun 1.
5
Serum thyrotropin concentration in children with isolated thyroid nodules.儿童孤立性甲状腺结节患者的血清促甲状腺素浓度。
J Pediatr. 2013 Nov;163(5):1465-70. doi: 10.1016/j.jpeds.2013.07.003. Epub 2013 Aug 22.
6
Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.血清促甲状腺激素浓度作为细针穿刺检查甲状腺结节恶性程度的一种新型预测指标。
J Clin Endocrinol Metab. 2006 Nov;91(11):4295-301. doi: 10.1210/jc.2006-0527. Epub 2006 Jul 25.
7
The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease.术前血清促甲状腺激素水平对预测甲状腺恶性结节性疾病的应用价值。
Am J Surg. 2010 Mar;199(3):294-7; discussion 298. doi: 10.1016/j.amjsurg.2009.08.028.
8
Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.结节性甲状腺疾病患者术前促甲状腺激素水平与甲状腺癌风险:结节大小的影响
Endocrinol Nutr. 2015 Jan;62(1):24-8. doi: 10.1016/j.endonu.2014.06.002. Epub 2014 Jul 25.
9
Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule.血清促甲状腺激素(TSH)是甲状腺微小结节的甲状腺功能正常患者甲状腺恶性肿瘤的危险因素。
Head Neck. 2012 Jul;34(7):949-52. doi: 10.1002/hed.21828. Epub 2011 Aug 24.
10
Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.促甲状腺激素(TSH)水平较低与甲状腺结节性疾病患者的甲状腺乳头状癌风险降低相关:甲状腺自主性可能发挥保护作用。
Endocr Relat Cancer. 2009 Dec;16(4):1251-60. doi: 10.1677/ERC-09-0036. Epub 2009 Jun 15.

引用本文的文献

1
A meta-analysis of the value of serum TSH concentration in the diagnosis of differentiated thyroid cancer in patients with thyroid nodules.甲状腺结节患者血清促甲状腺激素(TSH)浓度在分化型甲状腺癌诊断中价值的荟萃分析。
Heliyon. 2024 Jan 17;10(2):e24391. doi: 10.1016/j.heliyon.2024.e24391. eCollection 2024 Jan 30.
2
Association of Ultrasonography With Final Histopathology in Diagnosing Thyroid Malignancy: A Single-Institute Retrospective Study.超声检查与甲状腺恶性肿瘤最终组织病理学诊断的相关性:一项单机构回顾性研究。
Cureus. 2022 Nov 19;14(11):e31677. doi: 10.7759/cureus.31677. eCollection 2022 Nov.
3
Serum TSH levels are associated with postoperative recurrence and lymph node metastasis of papillary thyroid carcinoma.
血清促甲状腺激素水平与甲状腺乳头状癌术后复发及淋巴结转移相关。
Am J Transl Res. 2021 Jun 15;13(6):6108-6116. eCollection 2021.
4
Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review.亚临床甲状腺功能减退症与癌症发病率和癌症死亡率的风险:系统评价。
BMC Endocr Disord. 2020 Jun 9;20(1):83. doi: 10.1186/s12902-020-00566-9.
5
Thyroid Nodule Size and Prediction of Cancer: A Study at Tertiary Care Hospital in Saudi Arabia.甲状腺结节大小与癌症预测:沙特阿拉伯一家三级医疗医院的研究
Cureus. 2020 Mar 30;12(3):e7478. doi: 10.7759/cureus.7478.
6
2017 Chinese expert consensus on the clinical application of serum marker for thyroid cancer.《2017年甲状腺癌血清标志物临床应用中国专家共识》
Cancer Biol Med. 2018 Nov;15(4):468-477. doi: 10.20892/j.issn.2095-3941.2018.0084.
7
Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China.中国西南部云南高原地区甲状腺乳头状癌的危险因素
Ther Clin Risk Manag. 2016 Jun 30;12:1065-74. doi: 10.2147/TCRM.S105023. eCollection 2016.
8
Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer.术前血清促甲状腺激素水平与甲状腺癌的定量评估
Oncotarget. 2016 Jun 7;7(23):34918-29. doi: 10.18632/oncotarget.9201.